Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 940 | 23 | 233 | 266 | 622 |
| Gross Profit | 940 | 23 | 233 | 266 | 622 |
| Operating Expenses | 6,104 | 8,071 | 6,702 | 5,341 | 5,994 |
| Operating Income | -5,164 | -8,048 | -6,469 | -5,075 | -5,372 |
| Other Income | 35 | 38 | 46 | 54 | 52 |
| Pre-tax Income | -5,129 | -8,010 | -6,423 | -5,021 | -5,320 |
| Net Income Continuous | -5,129 | -8,010 | -6,423 | -5,021 | -5,320 |
| Net Income | $-5,129 | $-8,010 | $-6,423 | $-5,021 | $-5,320 |
| EPS Basic Total Ops | -0.23 | -0.36 | -0.30 | -0.25 | -0.29 |
| EPS Basic Continuous Ops | -0.23 | -0.37 | -0.30 | -0.25 | -0.29 |
| EPS Diluted Total Ops | -0.23 | -0.36 | -0.30 | -0.25 | -0.29 |
| EPS Diluted Continuous Ops | -0.23 | -0.37 | -0.30 | -0.25 | -0.29 |
| EBITDA(a) | $-5,027 | $-7,911 | $-6,336 | $-4,946 | $-5,247 |